Life Sciences

Ontario consults on changes to streamline drug formulary listing and reduce government payments to pharmacies

By Kristin Wall & William Chalmers on November 10, 2019

The Ontario Ministry of Health and Long-Term Care (the Ministry) has proposed draft amendments to Regulations made under the Ontario Drug Benefit Act (ODBA) and the Ontario Drug Interchangeability and Dispensing Fee Act. The proposed changes…

Pharma in brief – TMOB dismisses section 45 proceedings for the trade-mark REMODULIN

By Kristin Wall on March 21, 2017

Case: Blake, Cassels & Graydon LLP v United Therapeutics Corporation, 2017 TMOB 9

Trade-Mark: REMODULIN

Nature of case: Summary expungement proceedingpursuant to section 45 of Trade-marks Act

Successful party: United Therapeutics Corporation

Date of decision: January 26, 2017

Summary

…

Pharma in Brief

Life Sciences

Ontario consults on changes to streamline drug formulary listing and reduce government payments to pharmacies

Pharma in brief – TMOB dismisses section 45 proceedings for the trade-mark REMODULIN

Summary

About

Topics

Archives